Kenvue Inc.
Kenvue Inc. (KVUE) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · KVUE · as of Jun 8, 2026
Key Statistics
Explore Kenvue Inc. Data
kvue stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 14 · Buy rate: 28.6%
The KVUE analyst consensus is Hold, based on ratings from 14 Wall Street analysts over the past 3 months. The average 12-month price target is $18.25, representing +3.14% upside from the current price of $17.70.
Competitors & Peers
kvue competitorsKVUE
ADM
CHD
EL
HSY
JBSStock Performance
Full HistoryAbout Kenvue Inc.
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, c…
what is kenvue inc. · kvue stock overview · kenvue inc. company profile · who is kenvue inc. ceo · kvue NYSE · kenvue inc. headquarters · kenvue inc. business segments
About Stock Overview & Key Data
Kenvue Inc. (KVUE) is a Consumer Defensive company in the Household & Personal Products industry, listed on NYSE since May 4, 2023. As of the latest trading session, KVUE stock price is $17.70, with a market capitalization of $34.0B. The stock has returned -16.92% over the past 12 months and +2.58% year-to-date.
According to 14 Wall Street analysts, the consensus rating for Kenvue Inc. stock is Hold, with an average 12-month price target of $18.25. In fiscal year 2025, Kenvue Inc. reported revenue of $15.1B and net income of $1.5B. For detailed data — including Kenvue Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Kenvue Inc. (KVUE) stock price is $17.70. The stock is traded on NYSE under the ticker symbol KVUE. The 52-week range is $14.02 – $22.87.